Spotlight On Revolutionary Methylarginine Specific Antibody more>
CH3 BioSystems Contributes to Growth of Field of Protein Methylation more>
CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical
technology designed to identify and commercialize drug and diagnostic candidates.
We manufacture novel molecular tools to help biomedical research better understand cancer
and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions
of people around the world.
Our long-range vision is to facilitate the creation of diagnostic and pharmaceutical products
that are based on the emerging new field of protein methylation biology.